Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in symptomatic pulmonary arterial hypertension (SERAPHIN)
NCT00660179Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- May 2008
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 38
01
Overview
A Phase 3 trial of macitentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started May 2008; status: completed.
02
Drugs
macitentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00660179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660179.